Abivax S.A.

NASDAQ: ABVX · Real-Time Price · USD
71.89
2.93 (4.25%)
At close: Aug 20, 2025, 3:59 PM
71.15
-1.03%
Pre-market: Aug 21, 2025, 06:45 AM EDT

Abivax S.A. Income Statement

Financials in EUR. Fiscal year is January - December.
Fiscal Year Q4 2024 Q2 2024 Q4 2023 Q2 2023 Q4 2022 Q2 2022 Q4 2021 Q2 2021
Period Ending Dec 31, 2024 Jun 30, 2024 Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021
Revenue
10.79M 5.72M 4.57M 4.5M 4.48M 2.23M n/a n/a
Cost of Revenue
n/a 378K 707K 361K 71K 163K 156K 65K
Gross Profit
10.79M 5.72M 4.57M 4.5M 4.48M 2.1M -156K -65K
Operating Income
-172.98M -132.46M -132M -78.34M -57.43M -44.31M -52.22M -49.91M
Interest Income
n/a n/a n/a 113K 128K 99K 84K n/a
Pretax Income
-176.24M -138.86M -152.23M -96.74M -74.32M -59.19M -45.56M -42.85M
Net Income
-135.42M -136.61M -147.74M -92.25M -69.85M -54.38M -41.36M -38.66M
Selling & General & Admin
38.9M 43.69M 28.11M 11.85M 7.49M 4.52M 4.75M 4.73M
Research & Development
114.21M 102.88M 103.18M 65.46M 47.95M 38.35M 47.2M 45.01M
Other Expenses
41.74M -28K -7K -8K 10.93M 10.91M -113K -111K
Operating Expenses
183.78M 135.48M 131.29M 77.19M 66.25M 53.83M 52.06M 49.85M
Interest Expense
n/a 5.7M 20.4M 16.51M 3.93M 4.3M 3.21M 2.39M
Selling & Marketing Expenses
3.84M 8.01M 5.9M n/a n/a n/a n/a n/a
Cost & Expenses
183.78M 135.85M 132M 77.56M 56.65M 44.31M 52.22M 49.91M
Income Tax Expense
n/a -2.26M -4.49M -4.49M -4.48M -4.81M -4.2M -4.19M
Shares Outstanding (Basic)
63.17M 62.92M 48.29M 35.9M 22.3M 16.77M 16.76M 14.66M
Shares Outstanding (Diluted)
63.17M 62.92M 48.29M 35.9M 22.3M 16.77M 16.76M 14.66M
EPS (Basic)
-1.4 -2.63 -3.43 -3.26 -3.57 -3.24 -2.61 -2.68
EPS (Diluted)
-1.4 -2.63 -3.43 -3.26 -3.57 -3.24 -2.61 -2.68
EBITDA
-85.94M -132M -131.29M -75.35M -51.17M -40.58M -52.06M -49.85M
EBIT
-132.99M -132.34M -131.83M -75.67M -51.23M -40.29M -51.76M -49.87M
Depreciation & Amortization
550K 463.5K 707K 361K 71K 163K 156K 65K